
Vali oma silt
näidatakse otse viaalilLL-37
Immune System
- Saadetakse Saksamaalt
Tellimus
- DHL koos jälgimisega
- Diskreetne pakend
Lühidalt
LL-37 arvudes
Põhinäitajad meie leksikonist.
Täielik leksikoni artikkel- Class
- Antimicrobial peptidecathelicidin
- Half-life
- short
- Use
- Subcutaneousin mcg
- Sizes
- 5 to 10 mg2 sizes in the shop
What studies show
All 3 sources in the lexiconLL-37, the only human member of the cathelicidin family (review) (opens in a new tab)
Dürr, Sudheendra & Ramamoorthy, Biochimica et Biophysica Acta, 2006- Grönberg et al., Wound Repair and Regeneration, 2014
- Mahlapuu et al., Wound Repair and Regeneration, 2021
LL-37 jaoks pole veel laborianalüüsi. Hääleta selle pooltLase ise testida, meie maksame pooleKõik laborianalüüsid
Teadmised
Kõik teemal LL-37
Üksikasjalik teave tuleb peagi.
Annustamine
Annustamisteabe laadimine …
Telli kohe kaasa
Mida sul sellega vaja on
Bakteriostaatiline vesi lisatakse ostukorvi automaatselt. Süstlad ja lapid ühe klõpsuga.
Insuliinisüstlad
10 tk · 5.50 €
Alkoholilapid
50 tk · 10 €
Kui palju vett?
Ühikud süstlal sinu viaali suuruse jaoks.
Ava kalkulaator →Is LL-37 approved or studied in humans?
Not approved, but tested in humans. Only locally though: applied to hard-to-heal leg ulcers (one trial with 34 and one with 148 participants) and as an injection into melanoma metastases (4 participants). There is no trial with LL-37 injected under the skin. The information here describes the state of research.
Where does LL-37 come from in the body?
It is cleaved from the precursor hCAP18. Immune cells make it all the time, skin and mucous membranes mainly during inflammation and infection. In wounds the level rises until about 48 hours after the injury and falls again once the wound has closed. Immune cells also make it depending on vitamin D.
How does LL-37 work?
In two ways. It attaches to the membrane of bacteria and breaks it open. It also attracts immune cells such as neutrophils, monocytes and T cells, via the receptor FPR2 in cell studies. In a skin model it helps wounds close with new skin.
What did the wound trials show?
In the first trial with 34 participants leg ulcers healed about six and three times faster than with placebo at the two lower concentrations, the mean area fell by 68 and 50 percent. The highest concentration worked no better than placebo. The larger phase 2b trial with 148 participants found no overall difference, only a post hoc analysis of large wounds favoured LL-37.
Can LL-37 increase inflammation?
Yes, that has been described. In rosacea cathelicidin is strongly raised in the facial skin and cut differently, in mice these fragments triggered inflammation. In psoriasis LL-37 binds the body's own DNA and makes it visible to certain immune cells, which then release interferon. The entry points this out too.
Which side effects are known?
In both wound trials LL-37 was well tolerated, there were no safety concerns at the wound or in the body. There are no study data for LL-37 injected under the skin. The entry mentions possible reactions at the injection site because LL-37 attacks cell membranes.
Seotud
Seotud tooted
Thymosin Alpha-1
Peptiidid · Immuunsüsteem Immuunsüsteem
2 suurust
Laboris testitud
= alates 22 €/viaal
Thymalin
Peptiidid · Immuunsüsteem Immuunsüsteem
2 suurust
= alates 16 €/viaal
KPV
Peptiidid · Immuunsüsteem Immuunsüsteem
4 suurust
Laboris testitud
= alates 11.6 €/viaal
VIP
Peptiidid · Immuunsüsteem Immuunsüsteem
2 suurust
= alates 23.2 €/viaal
LL-37